Fleshner Neil's Insider Trades & SAST Disclosures
Fleshner Neil's most recent trade in POINT Biopharma Global Inc was a trade of 2,773,045 Common Stock done . Disclosure was reported to the exchange on Dec. 22, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Fleshner Neil.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| POINT Biopharma Global Inc | Fleshner Neil | Director, Chief Medical Officer | 22 Dec 2023 | 2,773,045 | 0 | - | - | Common Stock | ||
| POINT Biopharma Global Inc | Neil Fleshner | Director, Chief Medical Officer | 22 Dec 2023 | 233,171 | 0 | - | - | Common Stock | ||
| POINT Biopharma Global Inc | Neil Fleshner | Director, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Dec 2023 | 84,257 | 0 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Neil Fleshner | Director, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Dec 2023 | 60,234 | 0 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Fleshner Neil | Director, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Dec 2023 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Fleshner Neil | Director, Chief Medical Officer | 22 Dec 2023 | 358 | 0 | - | - | Common Stock | ||
| POINT Biopharma Global Inc | Neil Fleshner | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2023 | 84,257 | 84,257 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Neil Fleshner | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 25 May 2022 | 564,204 | 3,023,045 | - | 7.5 | 4,237,172 | Common Stock |
| POINT Biopharma Global Inc | Neil Fleshner | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 60,234 | 60,234 | - | - | Stock Option (Right to Buy) | |
| POINT Biopharma Global Inc | Neil Fleshner | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges